- Home
- ANIP vs SPH Comparison
ANIP vs SPH Comparison
Compare ANIP & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- SPH
- Stock Information
- Founded
- ANIP 2001
- SPH 1945
- Country
- ANIP United States
- SPH United States
- Employees
- ANIP N/A
- SPH N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- SPH Other Specialty Stores
- Sector
- ANIP Health Care
- SPH Consumer Discretionary
- Exchange
- ANIP Nasdaq
- SPH Nasdaq
- Market Cap
- ANIP 1.4B
- SPH 1.2B
- IPO Year
- ANIP N/A
- SPH 1996
- Fundamental
- Price
- ANIP $65.31
- SPH $18.21
- Analyst Decision
- ANIP Strong Buy
- SPH Sell
- Analyst Count
- ANIP 8
- SPH 1
- Target Price
- ANIP $80.13
- SPH $17.00
- AVG Volume (30 Days)
- ANIP 253.3K
- SPH 193.5K
- Earning Date
- ANIP 08-05-2025
- SPH 08-07-2025
- Dividend Yield
- ANIP N/A
- SPH 7.13%
- EPS Growth
- ANIP N/A
- SPH N/A
- EPS
- ANIP N/A
- SPH 1.46
- Revenue
- ANIP $674,068,000.00
- SPH $1,424,243,000.00
- Revenue This Year
- ANIP $30.52
- SPH $10.99
- Revenue Next Year
- ANIP $7.40
- SPH N/A
- P/E Ratio
- ANIP N/A
- SPH $12.49
- Revenue Growth
- ANIP 30.27
- SPH 4.02
- 52 Week Low
- ANIP $52.50
- SPH $15.20
- 52 Week High
- ANIP $77.00
- SPH $22.24
- Technical
- Relative Strength Index (RSI)
- ANIP 55.12
- SPH 42.98
- Support Level
- ANIP $63.17
- SPH $17.86
- Resistance Level
- ANIP $66.18
- SPH $18.47
- Average True Range (ATR)
- ANIP 1.83
- SPH 0.47
- MACD
- ANIP 0.00
- SPH 0.00
- Stochastic Oscillator
- ANIP 54.23
- SPH 22.73
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.